Cyclo Therapeutics Stock Price

-0.08 (-2.08%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 56,616
Bid Price 3.76
Ask Price 4.14
News -
Day High 3.98


52 Week Range


Day Low 3.7646
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Cyclo Therapeutics Inc CYTH NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.08 -2.08% 3.76 18:57:04
Open Price Low Price High Price Close Price Prev Close
3.85 3.7646 3.98 3.82 3.84
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
399 56,616 $ 3.84 $ 217,641 - 3.43 - 17.75
Last Trade Time Type Quantity Stock Price Currency
18:57:04 formt 100 $ 3.76 USD


Draw Mode:

Cyclo Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 31.60M 8.41M 7.77M $ 903.38k $ - -6.47 -1.10
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 46.65k -

more financials information »

Cyclo Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CYTH Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week4.504.503.76464.0987,051-0.74-16.44%
1 Month3.905.123.434.18124,386-0.14-3.59%
3 Months5.848.303.435.50186,149-2.08-35.62%
6 Months8.409.483.435.95109,600-4.64-55.24%
1 Year5.8617.753.439.55334,841-2.10-35.84%
3 Years4.1917.753.437.72534,125-0.43-10.26%
5 Years4.1917.753.437.72534,125-0.43-10.26%

Cyclo Therapeutics Description

Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company develops cyclodextrin-based products for the treatment of disease. Its lead drug candidate, Trappsol Cyclo, treats Niemann-Pick Type C disease (NPC). Its other products include Trappsol HPB, Trappsol Fine Chemical, and Aquaplex.

Your Recent History
Cyclo Ther..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.